Evolution Analytics Names Dan Kasher as Senior Vice President of Business Development
CHICAGO, IL, UNITED STATES, March 3, 2025 / EINPresswire.com / -- Evolution Analytics, a leading team of data analytics consultants specializing in AI-enabled analytics solutions, is pleased to announce that Dan Kasher has joined the company as Senior Vice President of Business Development.
With more than 25 years of experience in digital transformation, data analytics, and cloud strategy, Kasher has a proven track record of helping enterprises leverage data for strategic growth and operational excellence. His expertise strengthens Evolution Analytics' position as a go-to partner for businesses seeking top-tier data analytics consulting services.
Kasher joins Evolution Analytics after seven years at Trianz, where he played a key role in business development, sales strategy, and client engagement. At Trianz, he helped organizations accelerate cloud adoption, optimize data architectures, and implement AI-driven analytics solutions to drive measurable business impact.
Prior to Trianz, Kasher spent nearly eight years at CBIG Consulting, where he was instrumental in building and expanding the firm's data analytics consulting practice. He worked closely with enterprise clients to develop data monetization strategies, predictive analytics frameworks, and enterprise-wide business intelligence solutions. His contributions helped establish CBIG as a leader in data-driven digital transformation before its acquisition by Trianz in 2017.
'Dan's deep expertise in data-driven business transformation and his ability to align analytics with enterprise strategy make him an invaluable addition to our leadership team,' said Vince Belanger, Principal at Evolution Analytics. 'As demand for AI and advanced analytics continues to grow, Dan's leadership will be instrumental in expanding our client base and helping organizations harness the power of their data.'
Kasher has also held executive leadership roles at Slalom, Perficient, and the Federal Home Loan Bank of Chicago, where he spearheaded data modernization initiatives, cloud migration projects, and AI-driven business intelligence programs. His extensive background in AI, predictive analytics, enterprise data strategy, and digital transformation makes him a key driver of Evolution Analytics' growth strategy.
'I'm thrilled to join Evolution Analytics at such an exciting time in the AI and data analytics space,' said Dan Kasher. 'The company has built an outstanding reputation for helping organizations turn data into a competitive advantage. I look forward to working with the team to accelerate innovation and deliver game-changing analytics solutions for our clients.'
As SVP of Business Development, Kasher will focus on expanding strategic partnerships, strengthening client relationships, and driving new business opportunities across Evolution Analytics' core industries, including healthcare, life sciences, financial services, manufacturing, logistics, and private equity.
About Evolution Analytics
Evolution Analytics is an award-winning data analytics consulting firm specializing in AI-enabled solutions that drive business transformation. We partner with organizations across healthcare, finance, manufacturing, and other industries to plan, build, and implement advanced analytics systems that generate actionable insights and measurable results. With a business-first approach and a strong commitment to innovation, Evolution Analytics helps companies unlock the full potential of their data, enabling growth, efficiency, and operational excellence. For more information, visit https://www.evolutionanalytics.com/.
888-366-1966
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Raymond James Lowers Relay Therapeutics (RLAY) PT to $19 Following Q2 Results, Strategic Cost Cuts
Relay Therapeutics Inc. (NASDAQ:RLAY) is one of the most promising penny stocks under $5. On August 8, Raymond James lowered the firm's price target on Relay Therapeutics to $19 from $29, while keeping a Strong Buy rating on the shares. This sentiment followed Relay Therapeutics' Q2 2025 results, where OpEx was down 16% sequentially following strategic cost-cutting initiatives. Relay Therapeutics reported a net loss of $70.4 million, or $0.41 per share, in Q2 2025, which was an improvement compared to the net loss of $92.2 million, or $0.69 per share, in Q2 2024. Revenue for the quarter was $0.7 million, which was an increase from zero revenue in the same period last year. A chemist arranging containers of compounds, ready for the commercialization process. This quarter also featured the initiation of the Phase 3 ReDiscover-2 trial for RLY-2608 in Q2 2025. At the 2025 American Society for Clinical Oncology/ASCO Annual Meeting, updated interim data from the Phase 1b study for RLY-2608 were presented. In addition to oncology, Relay Therapeutics is continuing to execute its ongoing Phase 1 clinical trial for vascular malformations. Relay Therapeutics Inc. (NASDAQ:RLAY) is a clinical-stage precision medicines company that transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. While we acknowledge the potential of RLAY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
TD Cowen Lowers Clear Channel Outdoor (CCO) PT to $1.60 Despite Strong Q2 Performance
Clear Channel Outdoor Holdings Inc. (NYSE:CCO) is one of the most promising penny stocks under $5. Earlier on July 22, TD Cowen lowered the firm's price target on Clear Channel Outdoor to $1.60 from $1.70, while keeping a Buy rating on the shares. This sentiment by the firm came ahead of the company's Q2 2025 results, with expectations for higher consolidated revenue and outperformance in the Airport segment to offset softness in the America segment. Later in August, Clear Channel Outdoor Holdings' consolidated revenue came out to be $402.8 million in Q2, which was a 7% improvement year-over-year. The America segment recorded its highest-ever second-quarter revenue at $303.1 million due to robust digital and local sales. The Airports segment also performed strongly, with a 15.6% increase in revenue, reaching $99.7 million, powered by growth in both national and local sales channels. A busy street corner, with strategically placed advertisements to attract customers. However, the company's static advertising segment continues to lag behind digital growth. National sales in the America segment were also down 1% on a comparable basis. The company is still in the process of selling its business in Spain as well. Clear Channel Outdoor Holdings Inc. (NYSE:CCO) is an out-of-home advertising company in the US and Singapore. The company operates in 2 segments: America and Airports. While we acknowledge the potential of CCO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
While institutions invested in MA Financial Group Limited (ASX:MAF) benefited from last week's 7.1% gain, retail investors stood to gain the most
Explore MA Financial Group's Fair Values from the Community and select yours Key Insights The considerable ownership by retail investors in MA Financial Group indicates that they collectively have a greater say in management and business strategy A total of 8 investors have a majority stake in the company with 52% ownership Recent sales by insiders AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Every investor in MA Financial Group Limited (ASX:MAF) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 39% to be precise, is retail investors. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). Following a 7.1% increase in the stock price last week, retail investors profited the most, but institutions who own 27% stock also stood to gain from the increase. In the chart below, we zoom in on the different ownership groups of MA Financial Group. See our latest analysis for MA Financial Group What Does The Institutional Ownership Tell Us About MA Financial Group? Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing. As you can see, institutional investors have a fair amount of stake in MA Financial Group. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at MA Financial Group's earnings history below. Of course, the future is what really matters. Hedge funds don't have many shares in MA Financial Group. Because actions speak louder than words, we consider it a good sign when insiders own a significant stake in a company. In MA Financial Group's case, its Top Key Executive, Andrew Pridham, is the largest shareholder, holding 19% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 11% and 8.0%, of the shares outstanding, respectively. In addition, we found that Julian Biggins, the CEO has 3.1% of the shares allocated to their name. On further inspection, we found that more than half the company's shares are owned by the top 8 shareholders, suggesting that the interests of the larger shareholders are balanced out to an extent by the smaller ones. While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future. Insider Ownership Of MA Financial Group The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. Our most recent data indicates that insiders own a reasonable proportion of MA Financial Group Limited. It has a market capitalization of just AU$1.4b, and insiders have AU$374m worth of shares in their own names. We would say this shows alignment with shareholders, but it is worth noting that the company is still quite small; some insiders may have founded the business. You can click here to see if those insiders have been buying or selling. General Public Ownership With a 39% ownership, the general public, mostly comprising of individual investors, have some degree of sway over MA Financial Group. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run. Public Company Ownership It appears to us that public companies own 4.0% of MA Financial Group. It's hard to say for sure but this suggests they have entwined business interests. This might be a strategic stake, so it's worth watching this space for changes in ownership. Next Steps: It's always worth thinking about the different groups who own shares in a company. But to understand MA Financial Group better, we need to consider many other factors. For example, we've discovered 2 warning signs for MA Financial Group (1 is potentially serious!) that you should be aware of before investing here. If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
